Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-01-28 @ 7:41 PM
Study NCT ID:
NCT01804218
Status:
UNKNOWN
Last Update Posted:
2016-08-09
First Post:
2013-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Sponsor:
Invion, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Mild Persistent Asthma, Uncomplicated | View |
Keywords: